Trian believes Solventum would be a considerably more valuable company today if the Board and management are willing to take steps to realize its potential, including:

  1. Right-sizing overhead costs, driving net productivity and reinvesting in growth in order to reach (and exceed) performance levels Solventum delivered inside of 3M
  2. Simplifying its portfolio and divesting non-core businesses, starting with the immediate separation of the Health Information Systems ("HIS") business
  3. Improving capital allocation by prioritizing share repurchases at current levels